months, end of September 30, 2019 Financial Statement Consolidate financial statement % revenue from sales Q3/2019 Q3/2018 increase(decrease) Q3/2019 Q3/2018 Revenues from sales 159.78 140.51 19.27 13.71

ended 30 September 2020 are as follows: change Q3/2020 Q3/2019 increase (decrease) Sales 277.7 172.6 60.9% Other income 2.5 4.1 -39.9% Cost of sales - 207.6 - 159.6 -30.1% Selling expenses - 7.9 - 4.5

nine-month period ended September 30, 2018 and the nine-month period ended September 30, 2019, respectively. The figures represent a period-on-period increase of 65.46% due mainly to an increasing in

new share of CCPH. As a result of the Transaction, the Company and Kinpo Group shall hold the shares in CCPH at 19.19% and 80.81% of the total issued shares (after the increase of capital) respectively

. Expected Benefits to the Listed Company from the Transaction (1) To expand the scope of outsourced production service to cosmetic business; (2) To minimize the reliance on revenues from dietary supplement

parts of the Chonburi Plant, or increasing its capital later on. 8. Expected Benefits to the Listed Company from the Transaction (1) To expand the scope of outsourced production service to cosmetic

Public Company Limited (20 percent). Management Discussion and Analysis For the Three-month and Six-month Periods Ended 30 June, 201" Page 2 1.3 Secur ities Sale Deed to increase investment propor tion in

, Ended of September 30, 2018 Unit: Million Baht Power Generation Others Total Change Increase (Decrease) Quarter 3 Quarter 3 Quarter 3 Quarter 3 2018 2017 2018 2017 2018 2017 Amount % Total Revenues 10,140

18.9%, respectively. However those were in the opposite direction to the declining change in revenue due to the increase in employee-related expenses such as commission and salary. In addition, the

Infrastructure services and the Project of selling computer servers and equipment to increase the efficiency of information systems of Social Security Office, the Project for the maintenance of systems and